Detalles de la búsqueda
1.
Resident memory CD8+ T cells in regional lymph nodes mediate immunity to metastatic melanoma.
Immunity
; 54(9): 2117-2132.e7, 2021 09 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34525340
2.
Clinical influence of multiplex polymerase chain reaction routine uses in urgent pediatric admissions.
Pediatr Int
; 65(1): e15525, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36905298
3.
A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant.
Kidney Int
; 100(1): 196-205, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33359528
4.
Correction to: Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells.
Cancer Immunol Immunother
; 67(2): 327, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29264697
5.
Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells.
Cancer Immunol Immunother
; 67(2): 311-325, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29052782
6.
Physical and emotional well-being and support in newly diagnosed head and neck cancer patient-caregiver dyads.
J Psychosoc Oncol
; 35(6): 646-665, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28459393
7.
Anaplastic Lymphoma Kinase (ALK) Signaling in Lung Cancer.
Adv Exp Med Biol
; 893: 179-187, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26667344
8.
Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs.
JAMA
; 311(19): 1998-2006, 2014 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-24846037
9.
Rare immune-related adverse events in a patient with metastatic melanoma: a case report highlighting sarcoidosis-like reactions triggered by immune-checkpoint inhibitors.
Melanoma Res
; 34(1): 70-75, 2024 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37830935
10.
CD39 is expressed on functional effector and tissue resident memory CD8+ T cells.
bioRxiv
; 2024 Mar 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38559200
11.
Melanoma Surveillance Strategies: Different Approaches to a Shared Goal.
Ann Surg Oncol
; 25(3): 583-584, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29294186
12.
Evaluation of the role of secretory sphingomyelinase and bioactive sphingolipids as biomarkers in hemophagocytic lymphohistiocytosis.
Am J Hematol
; 88(11): E265-72, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23828274
13.
Durable complete response to early immunotherapy discontinuation in a kidney transplant recipient with advanced cutaneous squamous cell carcinoma: A case report and review of literature.
Transpl Immunol
; 81: 101932, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37734447
14.
Complete response of a large basosquamous carcinoma following treatment with cemiplimab and vismodegib.
BMJ Case Rep
; 16(7)2023 Jul 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37451798
15.
Oligometastatic Melanoma Treated by Metastasectomy in Combination with Immune Checkpoint and BRAF Inhibitors: A Case Series.
Am J Case Rep
; 24: e938537, 2023 Nov 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37978795
16.
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0.
J Immunother Cancer
; 11(10)2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37852736
17.
Clinical activity of PD-1 inhibition in the treatment of locally advanced or metastatic basal cell carcinoma.
J Immunother Cancer
; 10(5)2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35545318
18.
Secondary hemophagocytic syndrome in adults: a case series of 18 patients in a single institution and a review of literature.
Hematol Oncol
; 29(2): 100-6, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20809477
19.
Toxicity, response rates and survival outcomes of induction cisplatin and irinotecan followed by concurrent cisplatin, irinotecan and radiotherapy for locally advanced esophageal cancer.
Jpn J Clin Oncol
; 41(3): 334-42, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21084436
20.
Does denosumab offer survival benefits? -Our experience with denosumab in metastatic non-small cell lung cancer patients treated with immune-checkpoint inhibitors.
J Thorac Dis
; 13(8): 4668-4677, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34527308